Ravish Shammi Patel1, Chetan Anil Dhamne2, Anil Gopinathan3, Nishant Kumar1, Naresh Kumar4. 1. Department of Orthopaedic Surgery, National University Hospital, University Orthopaedics, Hand and Reconstructive Microsurgery Cluster, 1E Kent Ridge Road, NUHS Tower Block, Level 11, Singapore, 119228, Singapore. 2. Department of Paediatric Haematology and Oncology, National University Hospital, Singapore, Singapore. 3. Department of Diagnostic Imaging, National University Hospital, Singapore, Singapore. 4. Department of Orthopaedic Surgery, National University Hospital, University Orthopaedics, Hand and Reconstructive Microsurgery Cluster, 1E Kent Ridge Road, NUHS Tower Block, Level 11, Singapore, 119228, Singapore. dosksn@nus.edu.sg.
Abstract
PURPOSE: Aneurysmal bone cysts (ABCs) of spine are conventionally treated with en-bloc resection or intralesional excision/curettage and reconstruction or filling of defects with bone cement. For the treatment of upper cervical ABCs, en-bloc resections are often not desirable considering the risk/benefit ratio while the risk of recurrence after intralesional excision is high. Hence, alternative management options are often necessary. We describe our clinical experience with one such treatment alternative-denosumab for the treatment of ABC of Atlas. METHODS AND RESULTS: We present a case of 16-year-old boy who presented with neck pain and restriction of neck movements. A large lytic lesion with multiple fluid-fluid interfaces involving vertebral arch of atlas was identified on further imaging. There was destruction of right lateral mass and the lesion was found encasing the right vertebral artery. Core needle biopsy confirmed the diagnosis of ABC. With no visible CT response after first session of intra-lesional injection of Calcitonin and Methylprednisolone, the patient was treated with denosumab (120 mg SC once-a-month) for a period of 12 months. His symptoms resolved within 7 months of onset of treatment and serial CT scans over 12-month treatment period showed complete ossification of the lesion. Further there was no evidence of recurrence at 12 months after completion of treatment. CONCLUSION: Our case report contributes to the accruing evidence on the effectiveness of denosumab for the treatment of spinal ABCs. However, long-term safety, risk of recurrence, optimal duration of treatment and consistency of denosumab are yet to be determined.
PURPOSE:Aneurysmal bone cysts (ABCs) of spine are conventionally treated with en-bloc resection or intralesional excision/curettage and reconstruction or filling of defects with bone cement. For the treatment of upper cervical ABCs, en-bloc resections are often not desirable considering the risk/benefit ratio while the risk of recurrence after intralesional excision is high. Hence, alternative management options are often necessary. We describe our clinical experience with one such treatment alternative-denosumab for the treatment of ABC of Atlas. METHODS AND RESULTS: We present a case of 16-year-old boy who presented with neck pain and restriction of neck movements. A large lytic lesion with multiple fluid-fluid interfaces involving vertebral arch of atlas was identified on further imaging. There was destruction of right lateral mass and the lesion was found encasing the right vertebral artery. Core needle biopsy confirmed the diagnosis of ABC. With no visible CT response after first session of intra-lesional injection of Calcitonin and Methylprednisolone, the patient was treated with denosumab (120 mg SC once-a-month) for a period of 12 months. His symptoms resolved within 7 months of onset of treatment and serial CT scans over 12-month treatment period showed complete ossification of the lesion. Further there was no evidence of recurrence at 12 months after completion of treatment. CONCLUSION: Our case report contributes to the accruing evidence on the effectiveness of denosumab for the treatment of spinal ABCs. However, long-term safety, risk of recurrence, optimal duration of treatment and consistency of denosumab are yet to be determined.
Entities:
Keywords:
Aneurysmal bone cyst; Atlas; Denosumab; Methylprednisolone and calcitonin injection; Spine
Authors: George R Matcuk; Dakshesh B Patel; Aaron J Schein; Eric A White; Lawrence R Menendez Journal: Skeletal Radiol Date: 2015-02-26 Impact factor: 2.199
Authors: Dominic W Pelle; Jonathan W Ringler; Jacqueline D Peacock; Kevin Kampfschulte; Donald J Scholten; Mary M Davis; Deanna S Mitchell; Matthew R Steensma Journal: Transl Res Date: 2014-03-21 Impact factor: 7.012
Authors: Piotr Rutkowski; Stefano Ferrari; Robert J Grimer; Paul D Stalley; Sander P D Dijkstra; Andrzej Pienkowski; Gualter Vaz; Jay S Wunder; Leanne L Seeger; Amy Feng; Zachary J Roberts; Bruce A Bach Journal: Ann Surg Oncol Date: 2015-06-02 Impact factor: 5.344
Authors: Hans Roland Dürr; Ferdinand Grahneis; Andrea Baur-Melnyk; Thomas Knösel; Christof Birkenmaier; Volkmar Jansson; Alexander Klein Journal: BMC Musculoskelet Disord Date: 2019-10-20 Impact factor: 2.362
Authors: Giulia Del Sindaco; Pablo Berlanga; Laurence Brugières; Eric Thebault; Giovanna Mantovani; Philippe Wicart; Agnès Linglart Journal: Front Endocrinol (Lausanne) Date: 2021-07-16 Impact factor: 5.555